论文部分内容阅读
急性胃粘膜病变是许多危重病患者的常见并发症,在治疗原发病的基础上,我们采用泰胃美注射液预防各种危重病患者的急性胃粘膜病变取得了很满意的效果。现报告如下。 病例与方法 1 病例 危重病患者220例,其中男性140例,女性80例,年龄17～75岁,平均45岁。随机分成2组,预防组122例,男16例,女46例,年龄17～73岁,平均46岁。对照组98例,男性64例,女性34例,年龄19～75
Acute gastric mucosal lesion is a common complication in many critically ill patients. Based on the treatment of primary disease, we have obtained very satisfactory results by using Tai Weimei Injection in the prevention of acute gastric mucosal lesions in various critically ill patients. The report is as follows. Cases and methods 1 cases 220 cases of critically ill patients, including 140 males and 80 females, aged 17 to 75 years, mean 45 years. Randomly divided into two groups, prevention group 122 cases, 16 males and 46 females, aged 17 to 73 years, mean 46 years. The control group of 98 patients, 64 males and 34 females, aged 19 to 75